In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases DOI Creative Commons
Yuan Li, Fan Tong, Yufan Wang

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2024, Номер 14(9), С. 4102 - 4117

Опубликована: Июнь 12, 2024

Tumor vaccine, a promising modality of tumor immunotherapy, needs to go through the process antigen generation and loading, drainage lymph nodes (LNs), internalization by dendritic cells (DCs), DC maturation, cross-presentation activate T-cells. However, vaccines are often unable satisfy all steps, leading limitation their application efficacy. Herein, based on smart nanogel system, an

Язык: Английский

In Situ Vaccination with An Injectable Nucleic Acid Hydrogel for Synergistic Cancer Immunotherapy DOI Open Access
Fujun Wang,

Miao Xie,

Yangyang Huang

и другие.

Angewandte Chemie International Edition, Год журнала: 2023, Номер 63(4)

Опубликована: Ноя. 30, 2023

Abstract Recently, therapeutic cancer vaccines have emerged as promising candidates for immunotherapy. Nevertheless, their efficacies are frequently impeded by challenges including inadequate antigen encapsulation, insufficient immune activation, and immunosuppressive tumor microenvironment. Herein, we report a three‐in‐one hydrogel assembled nucleic acids (NAs) that can serve vaccine to in situ trigger strong response against cancer. Through site‐specifically grafting the chemodrug, 7‐ethyl‐10‐hydroxycamptothecin (also known SN38), onto three component phosphorothioate (PS) DNA strands, Y‐shaped motif (Y‐motif) with sticky ends is self‐assembled, at one terminus of which an unmethylated cytosine‐phosphate‐guanine (CpG) segment introduced agonist. Thereafter, programmed cell death ligand‐1 (PD‐L1) siRNA performs checkpoint inhibitor designed crosslinker assemble CpG‐ SN38‐containing Y‐motif, resulting formation final NA vaccine. With functional agents inside, remarkably induce immunogenic enhance presentation, promoting dendritic maturation effector T lymphocyte infiltration, well relieving environment. When inoculated twice sites, demonstrates substantial antitumor effect melanoma mouse model, proving its potential general platform synergistic

Язык: Английский

Процитировано

17

Advanced nanoscale delivery systems for mRNA-based vaccines DOI

Maha W. Mobasher,

Rais A. Ansari, Ana M. Castejón

и другие.

Biochimica et Biophysica Acta (BBA) - General Subjects, Год журнала: 2024, Номер 1868(3), С. 130558 - 130558

Опубликована: Янв. 5, 2024

Язык: Английский

Процитировано

8

Regulating Donor–Acceptor Interactions within 2-Methylpyridine-Mediated Vinylene-Linked Covalent–Organic Frameworks for Enhanced Photocatalysis DOI
Tao Feng,

Wenwen Zhou,

Zuyi Li

и другие.

ACS Materials Letters, Год журнала: 2024, Номер 6(4), С. 1120 - 1129

Опубликована: Фев. 26, 2024

Vinylene-linked covalent–oganic frameworks (COFs), as novel photocatalysts, have garnered considerable attention due to their exceptional stability, remarkable π-electron delocalization, and precisely customizable structures. However, the design of monomers for constructing vinylene-linked COFs with tunable electronic structures is still in its early stages poses a number challenges. Addressing this, tritopic monomer was developed by attaching 3-fold 2-methylpyridine unit triphenyl-1,3,5-triazine core. The further condensed aromatic dialdehydes via solid-state Knoevenagel polycondensation reaction form two 2D (TP-PB TP-PT COF), which exhibited excellent crystallinity, preeminent outstanding delocalization. More importantly, modulation donor–acceptor (D–A) interaction within COFs, semiconducting properties could be optimized. Due stronger D–A interactions TP-PB COF containing 1,3,5-triphenylbenzene than unit, broader visible light absorption, narrower band gap, photocurrent response, lower charge transfer resistance, makes more efficient photocatalyst photocatalytic selective conversions organic sulfides sulfoxides C-3 thiocyanation indole derivatives high catalytic activity recyclability. This work not only demonstrates construction but also presents facile strategy regulating such fine-tuning matrices.

Язык: Английский

Процитировано

7

Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances DOI

Gaoli Niu,

Hong Wang, Yanhong Zhai

и другие.

Nano Today, Год журнала: 2024, Номер 56, С. 102286 - 102286

Опубликована: Май 6, 2024

Язык: Английский

Процитировано

7

In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases DOI Creative Commons
Yuan Li, Fan Tong, Yufan Wang

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2024, Номер 14(9), С. 4102 - 4117

Опубликована: Июнь 12, 2024

Tumor vaccine, a promising modality of tumor immunotherapy, needs to go through the process antigen generation and loading, drainage lymph nodes (LNs), internalization by dendritic cells (DCs), DC maturation, cross-presentation activate T-cells. However, vaccines are often unable satisfy all steps, leading limitation their application efficacy. Herein, based on smart nanogel system, an

Язык: Английский

Процитировано

7